Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study

2014152 citationsJournal Article

Authors

ClinicalTrials.gov number: NCT01482884.

Good health and well-being

Published in: Gut

Volume 64, Issue 2, pp. 243-249

Field-Weighted Citation Impact: 13.22